CN104082722A - 一种防治肝炎的微生态制剂 - Google Patents
一种防治肝炎的微生态制剂 Download PDFInfo
- Publication number
- CN104082722A CN104082722A CN201410254391.XA CN201410254391A CN104082722A CN 104082722 A CN104082722 A CN 104082722A CN 201410254391 A CN201410254391 A CN 201410254391A CN 104082722 A CN104082722 A CN 104082722A
- Authority
- CN
- China
- Prior art keywords
- lactobacillus
- bifidobacterium
- powder
- add
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 40
- 208000006454 hepatitis Diseases 0.000 title claims abstract description 38
- 231100000283 hepatitis Toxicity 0.000 title claims abstract description 35
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 claims abstract description 39
- 235000009917 Crataegus X brevipes Nutrition 0.000 claims abstract description 38
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 claims abstract description 38
- 235000009685 Crataegus X maligna Nutrition 0.000 claims abstract description 38
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 claims abstract description 38
- 235000009486 Crataegus bullatus Nutrition 0.000 claims abstract description 38
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 claims abstract description 38
- 235000009682 Crataegus limnophila Nutrition 0.000 claims abstract description 38
- 240000000171 Crataegus monogyna Species 0.000 claims abstract description 38
- 235000004423 Crataegus monogyna Nutrition 0.000 claims abstract description 38
- 235000002313 Crataegus paludosa Nutrition 0.000 claims abstract description 38
- 235000009840 Crataegus x incaedua Nutrition 0.000 claims abstract description 38
- 244000111489 Gardenia augusta Species 0.000 claims abstract description 38
- 235000018958 Gardenia augusta Nutrition 0.000 claims abstract description 38
- 244000241838 Lycium barbarum Species 0.000 claims abstract description 38
- 235000015459 Lycium barbarum Nutrition 0.000 claims abstract description 38
- 210000000582 semen Anatomy 0.000 claims abstract description 28
- 244000197580 Poria cocos Species 0.000 claims abstract description 27
- 235000008599 Poria cocos Nutrition 0.000 claims abstract description 27
- 239000006041 probiotic Substances 0.000 claims abstract description 24
- 235000018291 probiotics Nutrition 0.000 claims abstract description 24
- 235000006487 Euryale ferox Nutrition 0.000 claims abstract description 20
- 244000268590 Euryale ferox Species 0.000 claims abstract description 20
- 239000000284 extract Substances 0.000 claims abstract description 16
- 244000183685 Citrus aurantium Species 0.000 claims abstract description 8
- 235000007716 Citrus aurantium Nutrition 0.000 claims abstract description 8
- 241000186660 Lactobacillus Species 0.000 claims description 112
- 229940039696 lactobacillus Drugs 0.000 claims description 112
- 239000000843 powder Substances 0.000 claims description 80
- 241000186000 Bifidobacterium Species 0.000 claims description 39
- 241000194020 Streptococcus thermophilus Species 0.000 claims description 39
- 238000000034 method Methods 0.000 claims description 39
- 244000037364 Cinnamomum aromaticum Species 0.000 claims description 38
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 claims description 38
- 240000001046 Lactobacillus acidophilus Species 0.000 claims description 38
- 235000013956 Lactobacillus acidophilus Nutrition 0.000 claims description 38
- 244000199866 Lactobacillus casei Species 0.000 claims description 38
- 235000013958 Lactobacillus casei Nutrition 0.000 claims description 38
- 241000245665 Taraxacum Species 0.000 claims description 38
- 229940039695 lactobacillus acidophilus Drugs 0.000 claims description 38
- 229940017800 lactobacillus casei Drugs 0.000 claims description 38
- 241000186018 Bifidobacterium adolescentis Species 0.000 claims description 37
- 241000901050 Bifidobacterium animalis subsp. lactis Species 0.000 claims description 37
- 241000186016 Bifidobacterium bifidum Species 0.000 claims description 37
- 241000186012 Bifidobacterium breve Species 0.000 claims description 37
- 241001608472 Bifidobacterium longum Species 0.000 claims description 37
- 241000186015 Bifidobacterium longum subsp. infantis Species 0.000 claims description 37
- 244000199885 Lactobacillus bulgaricus Species 0.000 claims description 37
- 235000013960 Lactobacillus bulgaricus Nutrition 0.000 claims description 37
- 241000186673 Lactobacillus delbrueckii Species 0.000 claims description 37
- 241000186840 Lactobacillus fermentum Species 0.000 claims description 37
- 241000186606 Lactobacillus gasseri Species 0.000 claims description 37
- 240000002605 Lactobacillus helveticus Species 0.000 claims description 37
- 235000013967 Lactobacillus helveticus Nutrition 0.000 claims description 37
- 240000006024 Lactobacillus plantarum Species 0.000 claims description 37
- 235000013965 Lactobacillus plantarum Nutrition 0.000 claims description 37
- 241000186604 Lactobacillus reuteri Species 0.000 claims description 37
- 241000218588 Lactobacillus rhamnosus Species 0.000 claims description 37
- 241000186869 Lactobacillus salivarius Species 0.000 claims description 37
- UQZIYBXSHAGNOE-USOSMYMVSA-N Stachyose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](CO[C@@H]2[C@@H](O)[C@@H](O)[C@@H](O)[C@H](CO)O2)O1 UQZIYBXSHAGNOE-USOSMYMVSA-N 0.000 claims description 37
- 229940002008 bifidobacterium bifidum Drugs 0.000 claims description 37
- 229940004120 bifidobacterium infantis Drugs 0.000 claims description 37
- 229940009289 bifidobacterium lactis Drugs 0.000 claims description 37
- 229940009291 bifidobacterium longum Drugs 0.000 claims description 37
- 210000000481 breast Anatomy 0.000 claims description 37
- 229940004208 lactobacillus bulgaricus Drugs 0.000 claims description 37
- 229940054346 lactobacillus helveticus Drugs 0.000 claims description 37
- 229940072205 lactobacillus plantarum Drugs 0.000 claims description 37
- 229940001882 lactobacillus reuteri Drugs 0.000 claims description 37
- UQZIYBXSHAGNOE-XNSRJBNMSA-N stachyose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO[C@@H]3[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O3)O)O2)O)O1 UQZIYBXSHAGNOE-XNSRJBNMSA-N 0.000 claims description 37
- 244000246386 Mentha pulegium Species 0.000 claims description 29
- 235000016257 Mentha pulegium Nutrition 0.000 claims description 29
- 235000004357 Mentha x piperita Nutrition 0.000 claims description 29
- 235000001050 hortel pimenta Nutrition 0.000 claims description 29
- 235000013305 food Nutrition 0.000 claims description 26
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims description 26
- 241000195493 Cryptophyta Species 0.000 claims description 25
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 20
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 20
- 235000002722 Dioscorea batatas Nutrition 0.000 claims description 20
- 235000006536 Dioscorea esculenta Nutrition 0.000 claims description 20
- 240000001811 Dioscorea oppositifolia Species 0.000 claims description 20
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 claims description 20
- 239000000463 material Substances 0.000 claims description 20
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims description 19
- 235000013399 edible fruits Nutrition 0.000 claims description 19
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims description 19
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims description 19
- 235000010447 xylitol Nutrition 0.000 claims description 19
- 239000000811 xylitol Substances 0.000 claims description 19
- 229960002675 xylitol Drugs 0.000 claims description 19
- WHGYBXFWUBPSRW-UHFFFAOYSA-N Cycloheptaamylose Natural products O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO WHGYBXFWUBPSRW-UHFFFAOYSA-N 0.000 claims description 18
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 claims description 18
- 235000013361 beverage Nutrition 0.000 claims description 18
- 235000015895 biscuits Nutrition 0.000 claims description 18
- 235000007215 black sesame Nutrition 0.000 claims description 18
- 239000002775 capsule Substances 0.000 claims description 18
- 230000003203 everyday effect Effects 0.000 claims description 18
- 235000013312 flour Nutrition 0.000 claims description 18
- 235000003599 food sweetener Nutrition 0.000 claims description 18
- 235000012054 meals Nutrition 0.000 claims description 18
- 238000009928 pasteurization Methods 0.000 claims description 18
- 238000002791 soaking Methods 0.000 claims description 18
- 239000007787 solid Substances 0.000 claims description 18
- 239000003765 sweetening agent Substances 0.000 claims description 18
- 244000077995 Coix lacryma jobi Species 0.000 claims description 17
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 claims description 14
- 241000251468 Actinopterygii Species 0.000 claims description 13
- MVORZMQFXBLMHM-QWRGUYRKSA-N Gly-His-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)CN)CC1=CN=CN1 MVORZMQFXBLMHM-QWRGUYRKSA-N 0.000 claims description 13
- 240000002853 Nelumbo nucifera Species 0.000 claims description 13
- 235000006508 Nelumbo nucifera Nutrition 0.000 claims description 13
- 235000006510 Nelumbo pentapetala Nutrition 0.000 claims description 13
- 101710093543 Probable non-specific lipid-transfer protein Proteins 0.000 claims description 13
- 244000046146 Pueraria lobata Species 0.000 claims description 13
- 235000010575 Pueraria lobata Nutrition 0.000 claims description 13
- 235000021323 fish oil Nutrition 0.000 claims description 13
- 108010038983 glycyl-histidyl-lysine Proteins 0.000 claims description 13
- 235000013336 milk Nutrition 0.000 claims description 13
- 239000008267 milk Substances 0.000 claims description 13
- 210000004080 milk Anatomy 0.000 claims description 13
- 229960003080 taurine Drugs 0.000 claims description 13
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 10
- 229930003268 Vitamin C Natural products 0.000 claims description 10
- 229930003427 Vitamin E Natural products 0.000 claims description 10
- FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical compound [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 claims description 10
- 235000019700 dicalcium phosphate Nutrition 0.000 claims description 10
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 10
- 235000019154 vitamin C Nutrition 0.000 claims description 10
- 239000011718 vitamin C Substances 0.000 claims description 10
- 235000019165 vitamin E Nutrition 0.000 claims description 10
- 229940046009 vitamin E Drugs 0.000 claims description 10
- 239000011709 vitamin E Substances 0.000 claims description 10
- 240000004307 Citrus medica Species 0.000 claims description 8
- 235000001938 Citrus medica Nutrition 0.000 claims description 8
- 235000002555 Citrus medica var sarcodactylis Nutrition 0.000 claims description 8
- TZCPCKNHXULUIY-RGULYWFUSA-N 1,2-distearoyl-sn-glycero-3-phosphoserine Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(=O)OC[C@H](N)C(O)=O)OC(=O)CCCCCCCCCCCCCCCCC TZCPCKNHXULUIY-RGULYWFUSA-N 0.000 claims description 7
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 claims description 7
- 235000007516 Chrysanthemum Nutrition 0.000 claims description 7
- 244000189548 Chrysanthemum x morifolium Species 0.000 claims description 7
- ZWZWYGMENQVNFU-UHFFFAOYSA-N Glycerophosphorylserin Natural products OC(=O)C(N)COP(O)(=O)OCC(O)CO ZWZWYGMENQVNFU-UHFFFAOYSA-N 0.000 claims description 7
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 claims description 7
- 244000234609 Portulaca oleracea Species 0.000 claims description 7
- 235000001855 Portulaca oleracea Nutrition 0.000 claims description 7
- 229930003537 Vitamin B3 Natural products 0.000 claims description 7
- 229960003512 nicotinic acid Drugs 0.000 claims description 7
- DFPAKSUCGFBDDF-UHFFFAOYSA-N nicotinic acid amide Natural products NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 claims description 7
- 229940055726 pantothenic acid Drugs 0.000 claims description 7
- 235000019161 pantothenic acid Nutrition 0.000 claims description 7
- 239000011713 pantothenic acid Substances 0.000 claims description 7
- 229940088594 vitamin Drugs 0.000 claims description 7
- 229930003231 vitamin Natural products 0.000 claims description 7
- 235000013343 vitamin Nutrition 0.000 claims description 7
- 239000011782 vitamin Substances 0.000 claims description 7
- 235000019160 vitamin B3 Nutrition 0.000 claims description 7
- 239000011708 vitamin B3 Substances 0.000 claims description 7
- 150000003722 vitamin derivatives Chemical class 0.000 claims description 7
- 229920002472 Starch Polymers 0.000 claims description 6
- 238000011156 evaluation Methods 0.000 claims description 6
- 235000013402 health food Nutrition 0.000 claims description 6
- 230000000144 pharmacologic effect Effects 0.000 claims description 6
- 235000019698 starch Nutrition 0.000 claims description 6
- 239000008107 starch Substances 0.000 claims description 6
- 244000068988 Glycine max Species 0.000 claims description 5
- 235000010469 Glycine max Nutrition 0.000 claims description 5
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 4
- 239000011701 zinc Substances 0.000 claims description 4
- 229910052725 zinc Inorganic materials 0.000 claims description 4
- 241001107116 Castanospermum australe Species 0.000 claims description 3
- 240000004638 Dendrobium nobile Species 0.000 claims description 3
- 241000628997 Flos Species 0.000 claims description 3
- 241000241413 Propolis Species 0.000 claims description 3
- -1 Semen sesami nigrum Chemical compound 0.000 claims description 3
- 235000021279 black bean Nutrition 0.000 claims description 3
- 239000012141 concentrate Substances 0.000 claims description 3
- 229940069949 propolis Drugs 0.000 claims description 3
- 239000003814 drug Substances 0.000 abstract description 13
- 235000005911 diet Nutrition 0.000 abstract description 8
- 230000037213 diet Effects 0.000 abstract description 6
- 230000008901 benefit Effects 0.000 abstract description 4
- 230000002265 prevention Effects 0.000 abstract description 4
- 230000036039 immunity Effects 0.000 abstract description 2
- 238000002560 therapeutic procedure Methods 0.000 abstract description 2
- 230000003110 anti-inflammatory effect Effects 0.000 abstract 2
- 241000411851 herbal medicine Species 0.000 abstract 2
- 235000000228 Citrus myrtifolia Nutrition 0.000 abstract 1
- 235000016646 Citrus taiwanica Nutrition 0.000 abstract 1
- 235000010955 Hovenia acerba Nutrition 0.000 abstract 1
- 241001533134 Hovenia acerba Species 0.000 abstract 1
- 235000006679 Mentha X verticillata Nutrition 0.000 abstract 1
- 235000002899 Mentha suaveolens Nutrition 0.000 abstract 1
- 235000001636 Mentha x rotundifolia Nutrition 0.000 abstract 1
- 241000037826 Polygonatum kingianum Species 0.000 abstract 1
- 240000001949 Taraxacum officinale Species 0.000 abstract 1
- 230000000975 bioactive effect Effects 0.000 abstract 1
- 230000002079 cooperative effect Effects 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 235000003715 nutritional status Nutrition 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 11
- 230000035622 drinking Effects 0.000 description 8
- 235000008216 herbs Nutrition 0.000 description 8
- 230000010354 integration Effects 0.000 description 8
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 6
- 238000010521 absorption reaction Methods 0.000 description 5
- 239000008280 blood Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 230000006378 damage Effects 0.000 description 4
- 230000036541 health Effects 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 4
- 235000012000 cholesterol Nutrition 0.000 description 3
- 230000003750 conditioning effect Effects 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 239000002574 poison Substances 0.000 description 3
- 231100000614 poison Toxicity 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 231100000331 toxic Toxicity 0.000 description 3
- 230000002588 toxic effect Effects 0.000 description 3
- 206010020772 Hypertension Diseases 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 208000019425 cirrhosis of liver Diseases 0.000 description 2
- 230000002354 daily effect Effects 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 230000000378 dietary effect Effects 0.000 description 2
- 230000000857 drug effect Effects 0.000 description 2
- 230000001077 hypotensive effect Effects 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000007659 motor function Effects 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 108010064733 Angiotensins Proteins 0.000 description 1
- 102000015427 Angiotensins Human genes 0.000 description 1
- 240000008620 Fagopyrum esculentum Species 0.000 description 1
- 235000009419 Fagopyrum esculentum Nutrition 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- 206010019799 Hepatitis viral Diseases 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- 102000007330 LDL Lipoproteins Human genes 0.000 description 1
- 108010007622 LDL Lipoproteins Proteins 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 239000002416 angiotensin derivative Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 210000004958 brain cell Anatomy 0.000 description 1
- 230000035568 catharsis Effects 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 230000007882 cirrhosis Effects 0.000 description 1
- 230000002860 competitive effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 230000009123 feedback regulation Effects 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 230000003862 health status Effects 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 208000005252 hepatitis A Diseases 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 208000021822 hypotensive Diseases 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 238000002483 medication Methods 0.000 description 1
- 239000003094 microcapsule Substances 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 206010036067 polydipsia Diseases 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 229940026314 red yeast rice Drugs 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 235000014102 seafood Nutrition 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 201000001862 viral hepatitis Diseases 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/21—Streptococcus, lactococcus
- A23V2400/249—Thermophilus
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/51—Bifidobacterium
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
本发明提供了一种防治肝炎的微生态制剂,该产品根据肝炎患者的体质特征,用传统中医精髓理论,有针对性的合理配伍:栀子、蒲公英、山楂、茯苓、决明子、枳椇子、麦芽、乌梅、黄精、薄荷、枸杞、代代花、芡实等药食两用中草药提取物,再添加多种抗炎益生菌制成。按照本发明配方制备的食品,易溶解,可快速吸收和利用,改善肝炎患者的营养状况,通过药食两用中草药提取物中的生物活性成分、多种抗炎益生菌等多种因子的共同作用,可以辅助提高机体免疫力,起到抑制肝炎作用,因此具有集食疗、预防、调理三重功效于一体的独特优势。
Description
技术领域
本发明属于药食同源类配方食品技术领域,具体是将 “药食同源之中药”的传统中医精髓理论和“多重益生菌”有机结合起来,适合一种防治肝炎的微生态制剂。
背景技术
肝炎的起因是:1外界的因素包括感染病毒,有甲肝炎毒、乙肝炎毒或者戊肝炎毒,从外界侵入体内,这是最常见的一种外来致病因素;2另外用药不当,肝脏的代谢器官也要受到伤害;俗话说“是药三分毒”,吃的药太多、太杂、剂量大,肝脏受不了,也会引起炎症;还有像饮酒,大量的饮酒,长期的酗酒,肝脏同样也会受到伤害;3自身的肝脏也可以由于免疫性的紊乱导致肝脏的发炎,所以内外两种因素都可以造成肝脏组织的发炎,形成肝炎;这些炎症持续不断,这些损坏因素迟迟不能剔除,慢慢发展,就到肝纤维化,最后发展到肝硬化,甚至于癌变;“药食同源”是中华原创医学之中对人类最有价值的贡献之一;五谷杂粮,有益于人类而无害于身体,因而性“中”;这是中华原创医学选择食品最主要的标准;这个标准是建立在“以人为本”的基础上的;中医历来强调“药疗不如食疗”,食疗成为现代人追求返璞归真、健康饮食的最佳选择;以食物为药物具有以下几大突出的优点:一、长期使用药物治病往往会产生各种副作用和依赖性,而且还可能对人体的健康造成影响;而食疗相对安全有效,毒副作用小;二、食疗使用的都是我们日常生活中常见的食物,价格低廉,让我们在日常用餐中便可达到调理的目的,这是昂贵的医药费所无法比拟的;三、食物为药还具有无痛苦的优点,让人们在享受美食的过程中祛除病痛,避免了打针、吃药,甚至手术之苦;
本人把“药食同源”与“新资源食品”的中药完美结合,将饮食与养生有机结合,以调理预防抵御肝炎,本发明属于药食同源及新资源类配方特膳食品技术领域,具体是一种适用于肝炎患者食用的特殊膳食;在继承中医的治病方法上,开创性利用:双歧杆菌、干酪乳杆菌、嗜热链球菌、嗜酸乳杆菌、等益生菌,调节肠内微生态平衡,促进对微量元素的吸收,增强脾胃运动功能,加速药效的吸收;同时根据肝炎体质特征,添加了多种天然的药食同源食材,具有集食疗、预防、调理三重功效于一体的独特优势。
发明目的
本发明的目的是提供一种在继承中医精髓理论治病方法上,开创性将多种抗肝炎益生菌与“药食同源之中药”复方的提取物有机结合起来,毒副作用小、安全有效,且人们容易接受的一种防治肝炎的微生态制剂。
发明内容
1,实现本发明目的一种防治肝炎的微生态制剂其包括以重量计的下列组分:微胶囊化后的双歧杆菌(青春双歧杆菌、乳双歧杆菌、两歧双歧杆菌、短双歧杆菌、婴儿双歧杆菌、长双歧杆菌)900g-1100g、乳杆菌(嗜酸乳杆菌粉、干酪乳杆菌、保加利亚乳杆菌、德氏乳杆菌、乳亚种格氏乳杆菌、发酵乳杆菌、瑞士乳杆菌、唾液乳杆菌、鼠李糖乳杆菌、罗伊氏乳杆菌、植物乳杆菌、副干酪乳杆菌、约氏乳杆菌)900g-1100g、嗜热链球菌900g-1100g、黑芝麻900g-1100g、黑豆900g-1100、莲子900g-1100g、薏苡仁900g-1100g、茯苓900g-1100g、栀子900g-1100g、山药900g-1100g、蒲公英900g-1100g、山楂900g-1100g、马齿苋900g-1100g、决明子900g-1100g、枳椇子900g-1100g、麦芽900g-1100g、乌梅900g-1100g、薄荷900g-1100g、枸杞900g-1100g、佛手900g-1100g、代代花900g-1100g、黄精900g-1100g、水苏糖900g-1100g、芡实900g-1100g、葛根粉800g-1000g、菊花700g-900g、低聚异麦芽糖700g-900g、海洋鱼低聚肽粉700g-900g、磷脂酰丝氨酸500g-700g、盐藻提取物500g-700g;泛酸600g-800g、磷酸氢钙600g-800g、鱼油提取物600g-800g、牛奶碱性蛋白600g-800g;维生素C300g-400g、维生素B300g-400g、维生素E300g-400g、牛磺酸200g-300g、锌100g-200g;
制作时先将以是栀子、蒲公英、山楂、马齿苋、茯苓、决明子、枳椇子、麦芽、乌梅、黄精、薄荷、枸杞、佛手、代代花、芡实、菊花浸泡后加入β-环状糊精,用预水解SBE技术提取并浓缩后, 经喷雾干燥而制备的粉状物质,配以葛根粉、山药、木糖醇、黑芝麻、黑豆粉、莲子粉、薏苡仁粉、水苏糖、低聚异麦芽糖、海洋鱼低聚肽粉、磷脂酰丝氨酸、盐藻提取物、泛酸、磷酸氢钙、鱼油提取物、牛奶碱性蛋白、维生素B、维生素C、维生素E、牛磺酸并混合后进行巴氏灭菌1小时,然后添加微胶囊化后的双歧杆菌(青春双歧杆菌、乳双歧杆菌、两歧双歧杆菌、短双歧杆菌、婴儿双歧杆菌、长双歧杆菌)、乳杆菌(嗜酸乳杆菌粉、干酪乳杆菌、保加利亚乳杆菌、德氏乳杆菌、乳亚种格氏乳杆菌、发酵乳杆菌、瑞士乳杆菌、唾液乳杆菌、鼠李糖乳杆菌、罗伊氏乳杆菌、植物乳杆菌、副干酪乳杆菌、约氏乳杆菌)、嗜热链球菌并混合的工艺制成固体饮料;然后分装成10-65ml/瓶(做成饮品则省略上述经喷雾干燥而制备一道工序),每日早、中、晚饭后0.5小时各饮1瓶,也可以加入适量附料制成胶囊、片剂或加入甜味剂和黑芝麻粉制成饼干等快速、方便食品便于外出携带食用;
上述所包括以重量计的各组分可以为:微胶囊化后的双歧杆菌(青春双歧杆菌、乳双歧杆菌、两歧双歧杆菌、短双歧杆菌、婴儿双歧杆菌、长双歧杆菌)900g-1100g、乳杆菌(嗜酸乳杆菌粉、干酪乳杆菌、保加利亚乳杆菌、德氏乳杆菌、乳亚种格氏乳杆菌、发酵乳杆菌、瑞士乳杆菌、唾液乳杆菌、鼠李糖乳杆菌、罗伊氏乳杆菌、植物乳杆菌、副干酪乳杆菌、约氏乳杆菌)900g-1100g、嗜热链球菌900g-1100g、黑芝麻900g-1100g、黑豆900g-1100、莲子900g-1100g、薏苡仁900g-1100g、茯苓900g-1100g、栀子900g-1100g、山药900g-1100g、蒲公英900g-1100g、山楂900g-1100g、马齿苋900g-1100g、决明子900g-1100g、枳椇子900g-1100g、麦芽900g-1100g、乌梅900g-1100g、薄荷900g-1100g、枸杞900g-1100g、佛手900g-1100g、代代花900g-1100g、黄精900g-1100g、水苏糖900g-1100g、芡实900g-1100g、葛根粉800g-1000g、菊花700g-900g、低聚异麦芽糖700g-900g、海洋鱼低聚肽粉700g-900g、磷脂酰丝氨酸500g-700g、盐藻提取物500g-700g;泛酸600g-800g、磷酸氢钙600g-800g、鱼油提取物600g-800g、牛奶碱性蛋白600g-800g;维生素C300g-400g、维生素B300g-400g、维生素E300g-400g、牛磺酸200g-300g、锌100g-200g。
2, 上述一种防治肝炎的微生态制剂其包括以重量计的下列组分:微胶囊化后的双歧杆菌(青春双歧杆菌、乳双歧杆菌、两歧双歧杆菌、短双歧杆菌、婴儿双歧杆菌、长双歧杆菌)900g-1100g、乳杆菌(嗜酸乳杆菌粉、干酪乳杆菌、保加利亚乳杆菌、德氏乳杆菌、乳亚种格氏乳杆菌、发酵乳杆菌、瑞士乳杆菌、唾液乳杆菌、鼠李糖乳杆菌、罗伊氏乳杆菌、植物乳杆菌、副干酪乳杆菌、约氏乳杆菌)900g-1100g、嗜热链球菌900g-1100g、黑芝麻900g-1100g、莲子900g-1100g、薏苡仁900g-1100g、茯苓900g-1100g、栀子900g-1100g、山药900g-1100g、蒲公英900g-1100g、山楂900g-1100g、决明子900g-1100g、麦芽900g-1100g、乌梅900g-1100g、薄荷900g-1100g、枸杞900g-1100g、黄精900g-1100g、水苏糖900g-1100g、芡实900g-1100g、葛根粉800g-1000g、低聚异麦芽糖700g-900g、海洋鱼低聚肽粉700g-900g、盐藻提取物500g-700g、鱼油提取物600g-800g、牛奶碱性蛋白600g-800g;维生素C300g-400g、维生素B300g-400g、维生素E300g-400g、牛磺酸200g-300g;
制作时先将以是栀子、蒲公英、山楂、决明子、茯苓、麦芽、乌梅、黄精、薄荷、枸杞、芡实浸泡后加入β-环状糊精,用预水解SBE技术提取后,经喷雾干燥而制备的粉状物质,配以木糖醇、黑芝麻、莲子粉、薏苡仁粉、水苏糖、共轭亚油酸、低聚异麦芽糖、海洋鱼低聚肽粉、盐藻提取物、磷酸氢钙、鱼油提取物、牛奶碱性蛋白、维生素、维生素 B、维生素、牛磺酸并混合后进行巴氏灭菌1小时,然后添加微胶囊化后的双歧杆菌(青春双歧杆菌、乳双歧杆菌、两歧双歧杆菌、短双歧杆菌、婴儿双歧杆菌、长双歧杆菌)、乳杆菌(嗜酸乳杆菌粉、干酪乳杆菌、保加利亚乳杆菌、德氏乳杆菌、乳亚种格氏乳杆菌、发酵乳杆菌、瑞士乳杆菌、唾液乳杆菌、鼠李糖乳杆菌、罗伊氏乳杆菌、植物乳杆菌、副干酪乳杆菌、约氏乳杆菌)、嗜热链球菌并混合的工艺制成固体饮料;然后分装成10-65ml/瓶(做成饮品则省略上述经喷雾干燥而制备一道工序),每日早、中、晚饭后0.5小时各饮1瓶,也可以加入适量辅料制成胶囊、片剂或加入甜味剂和黑芝麻粉制成饼干等快速、方便食品便于外出携带食用。
3,上述一种防治肝炎的微生态制剂其包括以重量计的下列组分:微胶囊化后的双歧杆菌(青春双歧杆菌、乳双歧杆菌、两歧双歧杆菌、短双歧杆菌、婴儿双歧杆菌、长双歧杆菌)900g-1100g、乳杆菌(嗜酸乳杆菌粉、干酪乳杆菌、保加利亚乳杆菌、德氏乳杆菌、乳亚种格氏乳杆菌、发酵乳杆菌、瑞士乳杆菌、唾液乳杆菌、鼠李糖乳杆菌、罗伊氏乳杆菌、植物乳杆菌、副干酪乳杆菌、约氏乳杆菌)900g-1100g、嗜热链球菌900g-1100g、黑芝麻900g-1100g、薏苡仁900g-1100g、栀子900g-1100g、山药900g-1100g、蒲公英900g-1100g、山楂900g-1100g、决明子900g-1100g、麦芽900g-1100g、乌梅900g-1100g、薄荷900g-1100g、枸杞900g-1100g、黄精900g-1100g、水苏糖900g-1100g、芡实900g-1100g、葛根粉800g-1000g、低聚异麦芽糖700g-900g、盐藻提取物500g-700g;;
制作时先将以是栀子、蒲公英、山楂、决明子、麦芽、乌梅、黄精、薄荷、枸杞、芡实浸泡后加入β-环状糊精,用预水解SBE技术提取后,经喷雾干燥而制备的粉状物质,配以木糖醇、黑芝麻、水苏糖、低聚异麦芽糖、盐藻提取物混合后进行巴氏灭菌1小时,然后添加微胶囊化后的双歧杆菌(青春双歧杆菌、乳双歧杆菌、两歧双歧杆菌、短双歧杆菌、婴儿双歧杆菌、长双歧杆菌)、乳杆菌(嗜酸乳杆菌粉、干酪乳杆菌、保加利亚乳杆菌、德氏乳杆菌、乳亚种格氏乳杆菌、发酵乳杆菌、瑞士乳杆菌、唾液乳杆菌、鼠李糖乳杆菌、罗伊氏乳杆菌、植物乳杆菌、副干酪乳杆菌、约氏乳杆菌)、嗜热链球菌并混合的工艺制成固体饮料;然后分装成10-65ml/瓶(做成饮品则省略上述经喷雾干燥而制备一道工序),每日早、中、晚饭后0.5小时各饮1瓶,也可以加入适量辅料制成胶囊、片剂或加入甜味剂和黑芝麻粉制成饼干等快速、方便食品便于外出携带食用。
4,上述一种防治肝炎的微生态制剂其包括以重量计的下列组分:微胶囊化后的双歧杆菌(青春双歧杆菌、乳双歧杆菌、两歧双歧杆菌、短双歧杆菌、婴儿双歧杆菌、长双歧杆菌)900g-1100g、乳杆菌(嗜酸乳杆菌粉、干酪乳杆菌、保加利亚乳杆菌、德氏乳杆菌、乳亚种格氏乳杆菌、发酵乳杆菌、瑞士乳杆菌、唾液乳杆菌、鼠李糖乳杆菌、罗伊氏乳杆菌、植物乳杆菌、副干酪乳杆菌、约氏乳杆菌)900g-1100g、嗜热链球菌900g-1100g、茯苓900g-1100g栀子900g-1100g、山药900g-1100g、蒲公英900g-1100g、山楂900g-1100g、决明子900g-1100g、麦芽900g-1100g、乌梅900g-1100g、薄荷900g-1100g、枸杞900g-1100g、黄精900g-1100g、水苏糖900g-1100g、共轭亚油酸700g-900g、低聚异麦芽糖700g-900g、盐藻提取物500g-700g;
制作时先将以是栀子、蒲公英、茯苓、山楂、决明子、麦芽、乌梅、薄荷、枸杞浸泡后加入β-环状糊精,用预水解SBE技术提取后,经喷雾干燥而制备的粉状物质配以木糖醇、水苏糖、低聚异麦芽糖、盐藻提取物混合后进行巴氏灭菌1小时,然后添加微胶囊化后的双歧杆菌(青春双歧杆菌、乳双歧杆菌、两歧双歧杆菌、短双歧杆菌、婴儿双歧杆菌、长双歧杆菌)、乳杆菌(嗜酸乳杆菌粉、干酪乳杆菌、保加利亚乳杆菌、德氏乳杆菌、乳亚种格氏乳杆菌、发酵乳杆菌、瑞士乳杆菌、唾液乳杆菌、鼠李糖乳杆菌、罗伊氏乳杆菌、植物乳杆菌、副干酪乳杆菌、约氏乳杆菌)、嗜热链球菌并混合的工艺制成固体饮料;然后分装成10-65ml/瓶(做成饮品则省略上述经喷雾干燥而制备一道工序),每日早、中、晚饭后0.5小时各饮1瓶,也可以加入适量辅料制成胶囊、片剂或加入甜味剂和黑芝麻粉制成饼干等快速、方便食品便于外出携带食用。
5,上述一种防治肝炎的微生态制剂其包括以重量计的下列组分:微胶囊化后的双歧杆菌(青春双歧杆菌、乳双歧杆菌、两歧双歧杆菌、短双歧杆菌、婴儿双歧杆菌、长双歧杆菌)900g-1100g、乳杆菌(嗜酸乳杆菌粉、干酪乳杆菌、保加利亚乳杆菌、德氏乳杆菌、乳亚种格氏乳杆菌、发酵乳杆菌、瑞士乳杆菌、唾液乳杆菌、鼠李糖乳杆菌、罗伊氏乳杆菌、植物乳杆菌、副干酪乳杆菌、约氏乳杆菌)900g-1100g、嗜热链球菌900g-1100g、茯苓900g-1100g、栀子900g-1100g、山药900g-1100g、蒲公英900g-1100g、山楂900g-1100g、决明子900g-1100g、麦芽900g-1100g、枸杞900g-1100g、黄精900g-1100g、水苏糖900g-1100g、低聚异麦芽糖900g-1100g;
制作时先将以是栀子、蒲公英、山楂、决明子、麦芽、茯苓、枸杞浸泡后加入β-环状糊精,用预水解SBE技术提取后,经喷雾干燥而制备的粉状物质配以木糖醇、水苏糖、低聚异麦芽糖混合后进行巴氏灭菌1小时,然后添加微胶囊化后的双歧杆菌(青春双歧杆菌、乳双歧杆菌、两歧双歧杆菌、短双歧杆菌、婴儿双歧杆菌、长双歧杆菌)、乳杆菌(嗜酸乳杆菌粉、干酪乳杆菌、保加利亚乳杆菌、德氏乳杆菌、乳亚种格氏乳杆菌、发酵乳杆菌、瑞士乳杆菌、唾液乳杆菌、鼠李糖乳杆菌、罗伊氏乳杆菌、植物乳杆菌、副干酪乳杆菌、约氏乳杆菌)、嗜热链球菌并混合的工艺制成固体饮料;然后分装成10-65ml/瓶(做成饮品则省略上述经喷雾干燥而制备一道工序),每日早、中、晚饭后0.5小时各饮1瓶,也可以加入适量辅料制成胶囊、片剂或加入甜味剂和黑芝麻粉制成饼干等快速、方便食品便于外出携带食用。
6,上述一种防治肝炎的微生态制剂其包括以重量计的下列组分:微胶囊化后的双歧杆菌(青春双歧杆菌、乳双歧杆菌、两歧双歧杆菌、短双歧杆菌、婴儿双歧杆菌、长双歧杆菌)900g-1100g、乳杆菌(嗜酸乳杆菌粉、干酪乳杆菌、保加利亚乳杆菌、德氏乳杆菌、乳亚种格氏乳杆菌、发酵乳杆菌、瑞士乳杆菌、唾液乳杆菌、鼠李糖乳杆菌、罗伊氏乳杆菌、植物乳杆菌、副干酪乳杆菌、约氏乳杆菌)900g-1100g、嗜热链球菌900g-1100g、栀子900g-1100g、蒲公英900g-1100g、山楂900g-1100g、决明子900g-1100g、麦芽900g-1100g、枸杞900g-1100g、黄精900g-1100g、水苏糖900g-1100g、低聚异麦芽糖900g-1100g;
制作时先将以是栀子、蒲公英、山楂、决明子、麦芽、薄荷、枸杞浸泡后加入β-环状糊精,用预水解SBE技术提取后,经喷雾干燥而制备的粉状物质,配以低聚异麦芽糖、木糖醇、水苏糖混合后进行巴氏灭菌1小时,然后添加微胶囊化后的双歧杆菌(青春双歧杆菌、乳双歧杆菌、两歧双歧杆菌、短双歧杆菌、婴儿双歧杆菌、长双歧杆菌)、乳杆菌(嗜酸乳杆菌粉、干酪乳杆菌、保加利亚乳杆菌、德氏乳杆菌、乳亚种格氏乳杆菌、发酵乳杆菌、瑞士乳杆菌、唾液乳杆菌、鼠李糖乳杆菌、罗伊氏乳杆菌、植物乳杆菌、副干酪乳杆菌、约氏乳杆菌)、嗜热链球菌并混合的工艺制成固体饮料;然后分装成10-65ml/瓶(做成饮品则省略上述经喷雾干燥而制备一道工序),每日早、中、晚饭后0.5小时各饮1瓶,也可以加入适量辅料制成胶囊、片剂或加入甜味剂和黑芝麻粉制成饼干等快速、方便食品便于外出携带食用。
前述的配方中(经药理实验,申报保健食品,并获取健字号后)还可以加入以重量计的下列组分:前述的配方中(经药理实验,申报保健食品,并获取健字号后)还可以加入以重量计的下列组分:石斛1600g-1400g、灵芝孢子粉(破壁)900g-1100g、蜂胶900g-1100g、厚朴花800g-1000g,用预水解SBE技术提取后加入。
本发明的一种防治肝炎的微生态制剂,根据肝炎的体质特征,利用中医体质平衡原理,有针对性的合理配伍山药、红曲米、薄荷、蒲公英、黑豆、佛手、低聚异麦芽糖等多种药食同源成份进行搭配,添加采用三层蛋白质深埋微胶囊技术微胶囊化后的乳杆菌、双歧杆菌、嗜热链球菌等,使益生菌能大部分通过胃的强酸环境到达肠道,以促进益生菌的增殖,调节肠内微生态平衡,促进对微量元素的吸收,增强脾胃运动功能,加速药效的吸收,具有通过饮食调节恢复人体平衡,达到稳定健康状态,减小致肝炎相关病症发展的效果,且以常见食物为主要原料,价格低廉,毒副作用小,安全有效,可作为特殊膳食,容易被人们接受。
具体实施方式
下面通过以下实施例对本发明作进一步说明,它将有助于理解本发明。
实施例一
实现本发明目的一种防治肝炎的微生态制剂及制备方法包括如下步骤,称取原料:微胶囊化后的双歧杆菌(青春双歧杆菌、乳双歧杆菌、两歧双歧杆菌、短双歧杆菌、婴儿双歧杆菌、长双歧杆菌)900g-1100g、乳杆菌(嗜酸乳杆菌粉、干酪乳杆菌、保加利亚乳杆菌、德氏乳杆菌、乳亚种格氏乳杆菌、发酵乳杆菌、瑞士乳杆菌、唾液乳杆菌、鼠李糖乳杆菌、罗伊氏乳杆菌、植物乳杆菌、副干酪乳杆菌、约氏乳杆菌)900g-1100g、嗜热链球菌900g-1100g、黑芝麻900g-1100g、黑豆900g-1100、莲子900g-1100g、薏苡仁900g-1100g、茯苓900g-1100g、栀子900g-1100g、山药900g-1100g、蒲公英900g-1100g、山楂900g-1100g、马齿苋900g-1100g、决明子900g-1100g、枳椇子900g-1100g、麦芽900g-1100g、乌梅900g-1100g、薄荷900g-1100g、枸杞900g-1100g、佛手900g-1100g、代代花900g-1100g、黄精900g-1100g、水苏糖900g-1100g、芡实900g-1100g、葛根粉800g-1000g、菊花700g-900g、低聚异麦芽糖700g-900g、海洋鱼低聚肽粉700g-900g、磷脂酰丝氨酸500g-700g、盐藻提取物500g-700g;泛酸600g-800g、磷酸氢钙600g-800g、鱼油提取物600g-800g、牛奶碱性蛋白600g-800g;维生素C300g-400g、维生素B300g-400g、维生素E300g-400g、牛磺酸200g-300g、锌100g-200g;
制作时先将以是栀子、蒲公英、山楂、马齿苋、茯苓、决明子、枳椇子、麦芽、乌梅、黄精、薄荷、枸杞、佛手、代代花、芡实、菊花浸泡后加入β-环状糊精,用预水解SBE技术提取并浓缩后, 经喷雾干燥而制备的粉状物质,配以葛根粉、山药、木糖醇、黑芝麻、黑豆粉、莲子粉、薏苡仁粉、水苏糖、低聚异麦芽糖、海洋鱼低聚肽粉、磷脂酰丝氨酸、盐藻提取物、泛酸、磷酸氢钙、鱼油提取物、牛奶碱性蛋白、维生素B、维生素C、维生素E、牛磺酸并混合后进行巴氏灭菌1小时,然后添加微胶囊化后的双歧杆菌(青春双歧杆菌、乳双歧杆菌、两歧双歧杆菌、短双歧杆菌、婴儿双歧杆菌、长双歧杆菌)、乳杆菌(嗜酸乳杆菌粉、干酪乳杆菌、保加利亚乳杆菌、德氏乳杆菌、乳亚种格氏乳杆菌、发酵乳杆菌、瑞士乳杆菌、唾液乳杆菌、鼠李糖乳杆菌、罗伊氏乳杆菌、植物乳杆菌、副干酪乳杆菌、约氏乳杆菌)、嗜热链球菌并混合的工艺制成固体饮料;然后分装成10-65ml/瓶(做成饮品则省略上述经喷雾干燥而制备一道工序),每日早、中、晚饭后0.5小时各饮1瓶,也可以加入适量附料制成胶囊、片剂或加入甜味剂和黑芝麻粉制成饼干等快速、方便食品便于外出携带食用。
实施例二
本发明的一种防治肝炎的微生态制剂及制备方法包括如下步骤,称取原料:微胶囊化后的双歧杆菌(青春双歧杆菌、乳双歧杆菌、两歧双歧杆菌、短双歧杆菌、婴儿双歧杆菌、长双歧杆菌)900g-1100g、乳杆菌(嗜酸乳杆菌粉、干酪乳杆菌、保加利亚乳杆菌、德氏乳杆菌、乳亚种格氏乳杆菌、发酵乳杆菌、瑞士乳杆菌、唾液乳杆菌、鼠李糖乳杆菌、罗伊氏乳杆菌、植物乳杆菌、副干酪乳杆菌、约氏乳杆菌)900g-1100g、嗜热链球菌900g-1100g、黑芝麻900g-1100g、莲子900g-1100g、薏苡仁900g-1100g、茯苓900g-1100g、栀子900g-1100g、山药900g-1100g、蒲公英900g-1100g、山楂900g-1100g、决明子900g-1100g、麦芽900g-1100g、乌梅900g-1100g、薄荷900g-1100g、枸杞900g-1100g、黄精900g-1100g、水苏糖900g-1100g、芡实900g-1100g、葛根粉800g-1000g、低聚异麦芽糖700g-900g、海洋鱼低聚肽粉700g-900g、盐藻提取物500g-700g、鱼油提取物600g-800g、牛奶碱性蛋白600g-800g;维生素C300g-400g、维生素B300g-400g、维生素E300g-400g、牛磺酸200g-300g;
制作时先将以是栀子、蒲公英、山楂、决明子、茯苓、麦芽、乌梅、黄精、薄荷、枸杞、芡实浸泡后加入β-环状糊精,用预水解SBE技术提取后,经喷雾干燥而制备的粉状物质,配以木糖醇、黑芝麻、莲子粉、薏苡仁粉、水苏糖、共轭亚油酸、低聚异麦芽糖、海洋鱼低聚肽粉、盐藻提取物、磷酸氢钙、鱼油提取物、牛奶碱性蛋白、维生素、维生素 B、维生素、牛磺酸并混合后进行巴氏灭菌1小时,然后添加微胶囊化后的双歧杆菌(青春双歧杆菌、乳双歧杆菌、两歧双歧杆菌、短双歧杆菌、婴儿双歧杆菌、长双歧杆菌)、乳杆菌(嗜酸乳杆菌粉、干酪乳杆菌、保加利亚乳杆菌、德氏乳杆菌、乳亚种格氏乳杆菌、发酵乳杆菌、瑞士乳杆菌、唾液乳杆菌、鼠李糖乳杆菌、罗伊氏乳杆菌、植物乳杆菌、副干酪乳杆菌、约氏乳杆菌)、嗜热链球菌并混合的工艺制成固体饮料;然后分装成10-65ml/瓶(做成饮品则省略上述经喷雾干燥而制备一道工序),每日早、中、晚饭后0.5小时各饮1瓶,也可以加入适量辅料制成胶囊、片剂或加入甜味剂和黑芝麻粉制成饼干等快速、方便食品便于外出携带食用。
实施例三
上述一种防治肝炎的微生态制剂其包括以重量计的下列组分:微胶囊化后的双歧杆菌(青春双歧杆菌、乳双歧杆菌、两歧双歧杆菌、短双歧杆菌、婴儿双歧杆菌、长双歧杆菌)900g-1100g、乳杆菌(嗜酸乳杆菌粉、干酪乳杆菌、保加利亚乳杆菌、德氏乳杆菌、乳亚种格氏乳杆菌、发酵乳杆菌、瑞士乳杆菌、唾液乳杆菌、鼠李糖乳杆菌、罗伊氏乳杆菌、植物乳杆菌、副干酪乳杆菌、约氏乳杆菌)900g-1100g、嗜热链球菌900g-1100g、黑芝麻900g-1100g、薏苡仁900g-1100g、栀子900g-1100g、山药900g-1100g、蒲公英900g-1100g、山楂900g-1100g、决明子900g-1100g、麦芽900g-1100g、乌梅900g-1100g、薄荷900g-1100g、枸杞900g-1100g、黄精900g-1100g、水苏糖900g-1100g、芡实900g-1100g、葛根粉800g-1000g、低聚异麦芽糖700g-900g、盐藻提取物500g-700g;;
制作时先将以是栀子、蒲公英、山楂、决明子、麦芽、乌梅、黄精、薄荷、枸杞、芡实浸泡后加入β-环状糊精,用预水解SBE技术提取后,经喷雾干燥而制备的粉状物质,配以木糖醇、黑芝麻、水苏糖、低聚异麦芽糖、盐藻提取物混合后进行巴氏灭菌1小时,然后添加微胶囊化后的双歧杆菌(青春双歧杆菌、乳双歧杆菌、两歧双歧杆菌、短双歧杆菌、婴儿双歧杆菌、长双歧杆菌)、乳杆菌(嗜酸乳杆菌粉、干酪乳杆菌、保加利亚乳杆菌、德氏乳杆菌、乳亚种格氏乳杆菌、发酵乳杆菌、瑞士乳杆菌、唾液乳杆菌、鼠李糖乳杆菌、罗伊氏乳杆菌、植物乳杆菌、副干酪乳杆菌、约氏乳杆菌)、嗜热链球菌并混合的工艺制成固体饮料;然后分装成10-65ml/瓶(做成饮品则省略上述经喷雾干燥而制备一道工序),每日早、中、晚饭后0.5小时各饮1瓶,也可以加入适量辅料制成胶囊、片剂或加入甜味剂和黑芝麻粉制成饼干等快速、方便食品便于外出携带食用。
实施例四
上述一种防治肝炎的微生态制剂其包括以重量计的下列组分:微胶囊化后的双歧杆菌(青春双歧杆菌、乳双歧杆菌、两歧双歧杆菌、短双歧杆菌、婴儿双歧杆菌、长双歧杆菌)900g-1100g、乳杆菌(嗜酸乳杆菌粉、干酪乳杆菌、保加利亚乳杆菌、德氏乳杆菌、乳亚种格氏乳杆菌、发酵乳杆菌、瑞士乳杆菌、唾液乳杆菌、鼠李糖乳杆菌、罗伊氏乳杆菌、植物乳杆菌、副干酪乳杆菌、约氏乳杆菌)900g-1100g、嗜热链球菌900g-1100g、茯苓900g-1100g栀子900g-1100g、山药900g-1100g、蒲公英900g-1100g、山楂900g-1100g、决明子900g-1100g、麦芽900g-1100g、乌梅900g-1100g、薄荷900g-1100g、枸杞900g-1100g、黄精900g-1100g、水苏糖900g-1100g、共轭亚油酸700g-900g、低聚异麦芽糖700g-900g、盐藻提取物500g-700g;
制作时先将以是栀子、蒲公英、茯苓、山楂、决明子、麦芽、乌梅、薄荷、枸杞浸泡后加入β-环状糊精,用预水解SBE技术提取后,经喷雾干燥而制备的粉状物质配以木糖醇、水苏糖、低聚异麦芽糖、盐藻提取物混合后进行巴氏灭菌1小时,然后添加微胶囊化后的双歧杆菌(青春双歧杆菌、乳双歧杆菌、两歧双歧杆菌、短双歧杆菌、婴儿双歧杆菌、长双歧杆菌)、乳杆菌(嗜酸乳杆菌粉、干酪乳杆菌、保加利亚乳杆菌、德氏乳杆菌、乳亚种格氏乳杆菌、发酵乳杆菌、瑞士乳杆菌、唾液乳杆菌、鼠李糖乳杆菌、罗伊氏乳杆菌、植物乳杆菌、副干酪乳杆菌、约氏乳杆菌)、嗜热链球菌并混合的工艺制成固体饮料;然后分装成10-65ml/瓶(做成饮品则省略上述经喷雾干燥而制备一道工序),每日早、中、晚饭后0.5小时各饮1瓶,也可以加入适量辅料制成胶囊、片剂或加入甜味剂和黑芝麻粉制成饼干等快速、方便食品便于外出携带食用。
实施例五
上述一种防治肝炎的微生态制剂其包括以重量计的下列组分:微胶囊化后的双歧杆菌(青春双歧杆菌、乳双歧杆菌、两歧双歧杆菌、短双歧杆菌、婴儿双歧杆菌、长双歧杆菌)900g-1100g、乳杆菌(嗜酸乳杆菌粉、干酪乳杆菌、保加利亚乳杆菌、德氏乳杆菌、乳亚种格氏乳杆菌、发酵乳杆菌、瑞士乳杆菌、唾液乳杆菌、鼠李糖乳杆菌、罗伊氏乳杆菌、植物乳杆菌、副干酪乳杆菌、约氏乳杆菌)900g-1100g、嗜热链球菌900g-1100g、茯苓900g-1100g、栀子900g-1100g、山药900g-1100g、蒲公英900g-1100g、山楂900g-1100g、决明子900g-1100g、麦芽900g-1100g、枸杞900g-1100g、黄精900g-1100g、水苏糖900g-1100g、低聚异麦芽糖900g-1100g;
制作时先将以是栀子、蒲公英、山楂、决明子、麦芽、茯苓、枸杞浸泡后加入β-环状糊精,用预水解SBE技术提取后,经喷雾干燥而制备的粉状物质配以木糖醇、水苏糖、低聚异麦芽糖混合后进行巴氏灭菌1小时,然后添加微胶囊化后的双歧杆菌(青春双歧杆菌、乳双歧杆菌、两歧双歧杆菌、短双歧杆菌、婴儿双歧杆菌、长双歧杆菌)、乳杆菌(嗜酸乳杆菌粉、干酪乳杆菌、保加利亚乳杆菌、德氏乳杆菌、乳亚种格氏乳杆菌、发酵乳杆菌、瑞士乳杆菌、唾液乳杆菌、鼠李糖乳杆菌、罗伊氏乳杆菌、植物乳杆菌、副干酪乳杆菌、约氏乳杆菌)、嗜热链球菌并混合的工艺制成固体饮料;然后分装成10-65ml/瓶(做成饮品则省略上述经喷雾干燥而制备一道工序),每日早、中、晚饭后0.5小时各饮1瓶,也可以加入适量辅料制成胶囊、片剂或加入甜味剂和黑芝麻粉制成饼干等快速、方便食品便于外出携带食用。
实施例六
上述一种防治肝炎的微生态制剂其包括以重量计的下列组分:微胶囊化后的双歧杆菌(青春双歧杆菌、乳双歧杆菌、两歧双歧杆菌、短双歧杆菌、婴儿双歧杆菌、长双歧杆菌)900g-1100g、乳杆菌(嗜酸乳杆菌粉、干酪乳杆菌、保加利亚乳杆菌、德氏乳杆菌、乳亚种格氏乳杆菌、发酵乳杆菌、瑞士乳杆菌、唾液乳杆菌、鼠李糖乳杆菌、罗伊氏乳杆菌、植物乳杆菌、副干酪乳杆菌、约氏乳杆菌)900g-1100g、嗜热链球菌900g-1100g、栀子900g-1100g、蒲公英900g-1100g、山楂900g-1100g、决明子900g-1100g、麦芽900g-1100g、枸杞900g-1100g、黄精900g-1100g、水苏糖900g-1100g、低聚异麦芽糖900g-1100g;
制作时先将以是栀子、蒲公英、山楂、决明子、麦芽、薄荷、枸杞浸泡后加入β-环状糊精,用预水解SBE技术提取后,经喷雾干燥而制备的粉状物质,配以低聚异麦芽糖、木糖醇、水苏糖混合后进行巴氏灭菌1小时,然后添加微胶囊化后的双歧杆菌(青春双歧杆菌、乳双歧杆菌、两歧双歧杆菌、短双歧杆菌、婴儿双歧杆菌、长双歧杆菌)、乳杆菌(嗜酸乳杆菌粉、干酪乳杆菌、保加利亚乳杆菌、德氏乳杆菌、乳亚种格氏乳杆菌、发酵乳杆菌、瑞士乳杆菌、唾液乳杆菌、鼠李糖乳杆菌、罗伊氏乳杆菌、植物乳杆菌、副干酪乳杆菌、约氏乳杆菌)、嗜热链球菌并混合的工艺制成固体饮料;然后分装成10-65ml/瓶(做成饮品则省略上述经喷雾干燥而制备一道工序),每日早、中、晚饭后0.5小时各饮1瓶,也可以加入适量辅料制成胶囊、片剂或加入甜味剂和黑芝麻粉制成饼干等快速、方便食品便于外出携带食用。
前述的配方中(经药理实验,申报保健食品,并获取健字号后)还可以加入以重量计的下列组分:前述的配方中(经药理实验,申报保健食品,并获取健字号后)还可以加入以重量计的下列组分:石斛1600g-1600g、灵芝孢子粉(破壁)900g-1100g、 蜂胶900g-1100g、厚朴花800g-1000g,用预水解SBE技术提取后加入。
上述的组合物中主要成份决明子有显著降低甘油三酯、胆固醇的含量的作用,通过导泻可减少肠道对胆固醇的吸收,并能反馈调节低密度脂蛋白的代谢,进而降脂,有助于大便通畅,并对心脏、血管、和肾脏等器官有保健作用,增强其动力,从而降低对血管壁的压力,达到降血压降血脂的功效;麦芽富含维生素和多种矿物质,可以降血压,同时还具有清热解毒、凉血润肺、预防中风的功效;薏苡仁能强效溶解血栓,预防高血压,抑制高血糖,防止脑细胞老化,降低胆固醇;黑芝麻作为一种血管紧张素的竞争性抑制剂,减轻血管紧张读,产生降压作用;茯苓有抑制血糖和脂肪的作用;荞麦有防治高血压,木糖醇有降低血压;维持正常的血糖水平;可以软化血管,延缓血管硬化的发生的作用。
Claims (7)
1.一种防治肝炎的微生态制剂,其特征在于包括以重量计的下列组分:微胶囊化后的双歧杆菌(青春双歧杆菌、乳双歧杆菌、两歧双歧杆菌、短双歧杆菌、婴儿双歧杆菌、长双歧杆菌)900g-1100g、乳杆菌(嗜酸乳杆菌粉、干酪乳杆菌、保加利亚乳杆菌、德氏乳杆菌、乳亚种格氏乳杆菌、发酵乳杆菌、瑞士乳杆菌、唾液乳杆菌、鼠李糖乳杆菌、罗伊氏乳杆菌、植物乳杆菌、副干酪乳杆菌、约氏乳杆菌)900g-1100g、嗜热链球菌900g-1100g、黑芝麻900g-1100g、黑豆900g-1100、莲子900g-1100g、薏苡仁900g-1100g、茯苓900g-1100g、栀子900g-1100g、山药900g-1100g、蒲公英900g-1100g、山楂900g-1100g、马齿苋900g-1100g、决明子900g-1100g、枳椇子900g-1100g、麦芽900g-1100g、乌梅900g-1100g、薄荷900g-1100g、枸杞900g-1100g、佛手900g-1100g、代代花900g-1100g、黄精900g-1100g、水苏糖900g-1100g、芡实900g-1100g、葛根粉800g-1000g、菊花700g-900g、低聚异麦芽糖700g-900g、海洋鱼低聚肽粉700g-900g、磷脂酰丝氨酸500g-700g、盐藻提取物500g-700g;泛酸600g-800g、磷酸氢钙600g-800g、鱼油提取物600g-800g、牛奶碱性蛋白600g-800g;维生素C300g-400g、维生素B300g-400g、维生素E300g-400g、牛磺酸200g-300g、锌100g-200g;
制作时先将以是栀子、蒲公英、山楂、马齿苋、茯苓、决明子、枳椇子、麦芽、乌梅、黄精、薄荷、枸杞、佛手、代代花、芡实、菊花浸泡后加入β-环状糊精,用预水解SBE技术提取并浓缩后, 经喷雾干燥而制备的粉状物质,配以葛根粉、山药、木糖醇、黑芝麻、黑豆粉、莲子粉、薏苡仁粉、水苏糖、低聚异麦芽糖、海洋鱼低聚肽粉、磷脂酰丝氨酸、盐藻提取物、泛酸、磷酸氢钙、鱼油提取物、牛奶碱性蛋白、维生素B、维生素C、维生素E、牛磺酸并混合后进行巴氏灭菌1小时,然后添加微胶囊化后的双歧杆菌(青春双歧杆菌、乳双歧杆菌、两歧双歧杆菌、短双歧杆菌、婴儿双歧杆菌、长双歧杆菌)、乳杆菌(嗜酸乳杆菌粉、干酪乳杆菌、保加利亚乳杆菌、德氏乳杆菌、乳亚种格氏乳杆菌、发酵乳杆菌、瑞士乳杆菌、唾液乳杆菌、鼠李糖乳杆菌、罗伊氏乳杆菌、植物乳杆菌、副干酪乳杆菌、约氏乳杆菌)、嗜热链球菌并混合的工艺制成固体饮料;然后分装成10-65ml/瓶(做成饮品则省略上述经喷雾干燥而制备一道工序),每日早、中、晚饭后0.5小时各饮1瓶,也可以加入适量附料制成胶囊、片剂或加入甜味剂和黑芝麻粉制成饼干等快速、方便食品便于外出携带食用。
2.根据权利要求1所述的防治肝炎的微生态制剂,其特征在于包括以重量计的下列组分:微胶囊化后的双歧杆菌(青春双歧杆菌、乳双歧杆菌、两歧双歧杆菌、短双歧杆菌、婴儿双歧杆菌、长双歧杆菌)900g-1100g、乳杆菌(嗜酸乳杆菌粉、干酪乳杆菌、保加利亚乳杆菌、德氏乳杆菌、乳亚种格氏乳杆菌、发酵乳杆菌、瑞士乳杆菌、唾液乳杆菌、鼠李糖乳杆菌、罗伊氏乳杆菌、植物乳杆菌、副干酪乳杆菌、约氏乳杆菌)900g-1100g、嗜热链球菌900g-1100g、黑芝麻900g-1100g、莲子900g-1100g、薏苡仁900g-1100g、茯苓900g-1100g、栀子900g-1100g、山药900g-1100g、蒲公英900g-1100g、山楂900g-1100g、决明子900g-1100g、麦芽900g-1100g、乌梅900g-1100g、薄荷900g-1100g、枸杞900g-1100g、黄精900g-1100g、水苏糖900g-1100g、芡实900g-1100g、葛根粉800g-1000g、低聚异麦芽糖700g-900g、海洋鱼低聚肽粉700g-900g、盐藻提取物500g-700g、鱼油提取物600g-800g、牛奶碱性蛋白600g-800g;维生素C300g-400g、维生素B300g-400g、维生素E300g-400g、牛磺酸200g-300g;
制作时先将以是栀子、蒲公英、山楂、决明子、茯苓、麦芽、乌梅、黄精、薄荷、枸杞、芡实浸泡后加入β-环状糊精,用预水解SBE技术提取后,经喷雾干燥而制备的粉状物质,配以木糖醇、黑芝麻、莲子粉、薏苡仁粉、水苏糖、共轭亚油酸、低聚异麦芽糖、海洋鱼低聚肽粉、盐藻提取物、磷酸氢钙、鱼油提取物、牛奶碱性蛋白、维生素、维生素 B、维生素、牛磺酸并混合后进行巴氏灭菌1小时,然后添加微胶囊化后的双歧杆菌(青春双歧杆菌、乳双歧杆菌、两歧双歧杆菌、短双歧杆菌、婴儿双歧杆菌、长双歧杆菌)、乳杆菌(嗜酸乳杆菌粉、干酪乳杆菌、保加利亚乳杆菌、德氏乳杆菌、乳亚种格氏乳杆菌、发酵乳杆菌、瑞士乳杆菌、唾液乳杆菌、鼠李糖乳杆菌、罗伊氏乳杆菌、植物乳杆菌、副干酪乳杆菌、约氏乳杆菌)、嗜热链球菌并混合的工艺制成固体饮料;然后分装成10-65ml/瓶(做成饮品则省略上述经喷雾干燥而制备一道工序),每日早、中、晚饭后0.5小时各饮1瓶,也可以加入适量辅料制成胶囊、片剂或加入甜味剂和黑芝麻粉制成饼干等快速、方便食品便于外出携带食用。
3.根据权利要求1所述的防治肝炎的微生态制剂,其特征在于包括以重量计的下列组分:微胶囊化后的双歧杆菌(青春双歧杆菌、乳双歧杆菌、两歧双歧杆菌、短双歧杆菌、婴儿双歧杆菌、长双歧杆菌)900g-1100g、乳杆菌(嗜酸乳杆菌粉、干酪乳杆菌、保加利亚乳杆菌、德氏乳杆菌、乳亚种格氏乳杆菌、发酵乳杆菌、瑞士乳杆菌、唾液乳杆菌、鼠李糖乳杆菌、罗伊氏乳杆菌、植物乳杆菌、副干酪乳杆菌、约氏乳杆菌)900g-1100g、嗜热链球菌900g-1100g、黑芝麻900g-1100g、薏苡仁900g-1100g、栀子900g-1100g、山药900g-1100g、蒲公英900g-1100g、山楂900g-1100g、决明子900g-1100g、麦芽900g-1100g、乌梅900g-1100g、薄荷900g-1100g、枸杞900g-1100g、黄精900g-1100g、水苏糖900g-1100g、芡实900g-1100g、葛根粉800g-1000g、低聚异麦芽糖700g-900g、盐藻提取物500g-700g;;
制作时先将以是栀子、蒲公英、山楂、决明子、麦芽、乌梅、黄精、薄荷、枸杞、芡实浸泡后加入β-环状糊精,用预水解SBE技术提取后,经喷雾干燥而制备的粉状物质,配以木糖醇、黑芝麻、水苏糖、低聚异麦芽糖、盐藻提取物混合后进行巴氏灭菌1小时,然后添加微胶囊化后的双歧杆菌(青春双歧杆菌、乳双歧杆菌、两歧双歧杆菌、短双歧杆菌、婴儿双歧杆菌、长双歧杆菌)、乳杆菌(嗜酸乳杆菌粉、干酪乳杆菌、保加利亚乳杆菌、德氏乳杆菌、乳亚种格氏乳杆菌、发酵乳杆菌、瑞士乳杆菌、唾液乳杆菌、鼠李糖乳杆菌、罗伊氏乳杆菌、植物乳杆菌、副干酪乳杆菌、约氏乳杆菌)、嗜热链球菌并混合的工艺制成固体饮料;然后分装成10-65ml/瓶(做成饮品则省略上述经喷雾干燥而制备一道工序),每日早、中、晚饭后0.5小时各饮1瓶,也可以加入适量辅料制成胶囊、片剂或加入甜味剂和黑芝麻粉制成饼干等快速、方便食品便于外出携带食用。
4.根据权利要求1所述的防治肝炎的微生态制剂,其特征在于包括以重量计的下列组分:微胶囊化后的双歧杆菌(青春双歧杆菌、乳双歧杆菌、两歧双歧杆菌、短双歧杆菌、婴儿双歧杆菌、长双歧杆菌)900g-1100g、乳杆菌(嗜酸乳杆菌粉、干酪乳杆菌、保加利亚乳杆菌、德氏乳杆菌、乳亚种格氏乳杆菌、发酵乳杆菌、瑞士乳杆菌、唾液乳杆菌、鼠李糖乳杆菌、罗伊氏乳杆菌、植物乳杆菌、副干酪乳杆菌、约氏乳杆菌)900g-1100g、嗜热链球菌900g-1100g、茯苓900g-1100g栀子900g-1100g、山药900g-1100g、蒲公英900g-1100g、山楂900g-1100g、决明子900g-1100g、麦芽900g-1100g、乌梅900g-1100g、薄荷900g-1100g、枸杞900g-1100g、黄精900g-1100g、水苏糖900g-1100g、共轭亚油酸700g-900g、低聚异麦芽糖700g-900g、盐藻提取物500g-700g;
制作时先将以是栀子、蒲公英、茯苓、山楂、决明子、麦芽、乌梅、薄荷、枸杞浸泡后加入β-环状糊精,用预水解SBE技术提取后,经喷雾干燥而制备的粉状物质配以木糖醇、水苏糖、低聚异麦芽糖、盐藻提取物混合后进行巴氏灭菌1小时,然后添加微胶囊化后的双歧杆菌(青春双歧杆菌、乳双歧杆菌、两歧双歧杆菌、短双歧杆菌、婴儿双歧杆菌、长双歧杆菌)、乳杆菌(嗜酸乳杆菌粉、干酪乳杆菌、保加利亚乳杆菌、德氏乳杆菌、乳亚种格氏乳杆菌、发酵乳杆菌、瑞士乳杆菌、唾液乳杆菌、鼠李糖乳杆菌、罗伊氏乳杆菌、植物乳杆菌、副干酪乳杆菌、约氏乳杆菌)、嗜热链球菌并混合的工艺制成固体饮料;然后分装成10-65ml/瓶(做成饮品则省略上述经喷雾干燥而制备一道工序),每日早、中、晚饭后0.5小时各饮1瓶,也可以加入适量辅料制成胶囊、片剂或加入甜味剂和黑芝麻粉制成饼干等快速、方便食品便于外出携带食用。
5.根据权利要求1所述的防治肝炎的微生态制剂,其特征在于包括以重量计的下列组分:微胶囊化后的双歧杆菌(青春双歧杆菌、乳双歧杆菌、两歧双歧杆菌、短双歧杆菌、婴儿双歧杆菌、长双歧杆菌)900g-1100g、乳杆菌(嗜酸乳杆菌粉、干酪乳杆菌、保加利亚乳杆菌、德氏乳杆菌、乳亚种格氏乳杆菌、发酵乳杆菌、瑞士乳杆菌、唾液乳杆菌、鼠李糖乳杆菌、罗伊氏乳杆菌、植物乳杆菌、副干酪乳杆菌、约氏乳杆菌)900g-1100g、嗜热链球菌900g-1100g、茯苓900g-1100g、栀子900g-1100g、山药900g-1100g、蒲公英900g-1100g、山楂900g-1100g、决明子900g-1100g、麦芽900g-1100g、枸杞900g-1100g、黄精900g-1100g、水苏糖900g-1100g、低聚异麦芽糖900g-1100g;
制作时先将以是栀子、蒲公英、山楂、决明子、麦芽、茯苓、枸杞浸泡后加入β-环状糊精,用预水解SBE技术提取后,经喷雾干燥而制备的粉状物质配以木糖醇、水苏糖、低聚异麦芽糖混合后进行巴氏灭菌1小时,然后添加微胶囊化后的双歧杆菌(青春双歧杆菌、乳双歧杆菌、两歧双歧杆菌、短双歧杆菌、婴儿双歧杆菌、长双歧杆菌)、乳杆菌(嗜酸乳杆菌粉、干酪乳杆菌、保加利亚乳杆菌、德氏乳杆菌、乳亚种格氏乳杆菌、发酵乳杆菌、瑞士乳杆菌、唾液乳杆菌、鼠李糖乳杆菌、罗伊氏乳杆菌、植物乳杆菌、副干酪乳杆菌、约氏乳杆菌)、嗜热链球菌并混合的工艺制成固体饮料;然后分装成10-65ml/瓶(做成饮品则省略上述经喷雾干燥而制备一道工序),每日早、中、晚饭后0.5小时各饮1瓶,也可以加入适量辅料制成胶囊、片剂或加入甜味剂和黑芝麻粉制成饼干等快速、方便食品便于外出携带食用。
6.根据权利要求1所述的防治肝炎的微生态制剂,其特征在于包括以重量计的下列组分:微胶囊化后的双歧杆菌(青春双歧杆菌、乳双歧杆菌、两歧双歧杆菌、短双歧杆菌、婴儿双歧杆菌、长双歧杆菌)900g-1100g、乳杆菌(嗜酸乳杆菌粉、干酪乳杆菌、保加利亚乳杆菌、德氏乳杆菌、乳亚种格氏乳杆菌、发酵乳杆菌、瑞士乳杆菌、唾液乳杆菌、鼠李糖乳杆菌、罗伊氏乳杆菌、植物乳杆菌、副干酪乳杆菌、约氏乳杆菌)900g-1100g、嗜热链球菌900g-1100g、栀子900g-1100g、蒲公英900g-1100g、山楂900g-1100g、决明子900g-1100g、麦芽900g-1100g、枸杞900g-1100g、黄精900g-1100g、水苏糖900g-1100g、低聚异麦芽糖900g-1100g;
制作时先将以是栀子、蒲公英、山楂、决明子、麦芽、薄荷、枸杞浸泡后加入β-环状糊精,用预水解SBE技术提取后,经喷雾干燥而制备的粉状物质,配以低聚异麦芽糖、木糖醇、水苏糖混合后进行巴氏灭菌1小时,然后添加微胶囊化后的双歧杆菌(青春双歧杆菌、乳双歧杆菌、两歧双歧杆菌、短双歧杆菌、婴儿双歧杆菌、长双歧杆菌)、乳杆菌(嗜酸乳杆菌粉、干酪乳杆菌、保加利亚乳杆菌、德氏乳杆菌、乳亚种格氏乳杆菌、发酵乳杆菌、瑞士乳杆菌、唾液乳杆菌、鼠李糖乳杆菌、罗伊氏乳杆菌、植物乳杆菌、副干酪乳杆菌、约氏乳杆菌)、嗜热链球菌并混合的工艺制成固体饮料;然后分装成10-65ml/瓶(做成饮品则省略上述经喷雾干燥而制备一道工序),每日早、中、晚饭后0.5小时各饮1瓶,也可以加入适量辅料制成胶囊、片剂或加入甜味剂和黑芝麻粉制成饼干等快速、方便食品便于外出携带食用。
7.前述的配方中(经药理实验,申报保健食品,并获取健字号后)还可以加入以重量计的下列组分:前述的配方中(经药理实验,申报保健食品,并获取健字号后)还可以加入以重量计的下列组分:石斛1600g-1400g、灵芝孢子粉(破壁)900g-1100g、 蜂胶900g-1100g、厚朴花800g-1000g,用预水解SBE技术提取后加入。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410254391.XA CN104082722A (zh) | 2014-06-10 | 2014-06-10 | 一种防治肝炎的微生态制剂 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410254391.XA CN104082722A (zh) | 2014-06-10 | 2014-06-10 | 一种防治肝炎的微生态制剂 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN104082722A true CN104082722A (zh) | 2014-10-08 |
Family
ID=51630570
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410254391.XA Pending CN104082722A (zh) | 2014-06-10 | 2014-06-10 | 一种防治肝炎的微生态制剂 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104082722A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107050148A (zh) * | 2017-06-13 | 2017-08-18 | 广州中天康顺生物医药有限公司 | 一种解酒保肝中药组合物及其制备方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101496577A (zh) * | 2008-01-28 | 2009-08-05 | 中国食品发酵工业研究院 | 一种供肾病患者食用含短肽的特殊膳食用食品配方 |
CN103461985A (zh) * | 2013-07-18 | 2013-12-25 | 浙江劲膳美生物科技有限公司 | 一种肝病患者食用的特殊膳食 |
CN103637182A (zh) * | 2013-11-01 | 2014-03-19 | 胡安然 | 一种免疫力低患者的特殊膳食 |
-
2014
- 2014-06-10 CN CN201410254391.XA patent/CN104082722A/zh active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101496577A (zh) * | 2008-01-28 | 2009-08-05 | 中国食品发酵工业研究院 | 一种供肾病患者食用含短肽的特殊膳食用食品配方 |
CN103461985A (zh) * | 2013-07-18 | 2013-12-25 | 浙江劲膳美生物科技有限公司 | 一种肝病患者食用的特殊膳食 |
CN103637182A (zh) * | 2013-11-01 | 2014-03-19 | 胡安然 | 一种免疫力低患者的特殊膳食 |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107050148A (zh) * | 2017-06-13 | 2017-08-18 | 广州中天康顺生物医药有限公司 | 一种解酒保肝中药组合物及其制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103404758B (zh) | 一种胃溃疡患者食用的特殊膳食 | |
CN103462028B (zh) | 一种贫血体质者食用的特殊膳食 | |
CN103689593A (zh) | 一种调理慢性浅表性胃炎的膳食 | |
CN103431261B (zh) | 一种脾胃虚寒患者食用的特殊膳食 | |
CN103445178B (zh) | 一种慢性浅表性胃炎患者食用的特殊膳食 | |
CN103907927B (zh) | 一种调理特禀体质的膳食 | |
CN104223057A (zh) | 肝病全营养配方食品 | |
CN104082717A (zh) | 一种肝肿瘤患者食用的微生态特殊膳食 | |
CN103431375B (zh) | 一种抑郁症患者食用的特殊膳食 | |
CN104055109A (zh) | 一种降三高壮阳的特殊膳食 | |
CN104055012A (zh) | 一种防治高血脂的微生态制剂 | |
CN104172168A (zh) | 一种调理动脉粥样硬化的方便食品 | |
CN104012949A (zh) | 一种调理失眠的膳食 | |
CN104012989A (zh) | 一种调理阴虚体质的膳食 | |
CN104187741A (zh) | 心脏病全营养配方食品 | |
CN104161266A (zh) | 脾胃虚寒全营养配方食品 | |
CN104068405A (zh) | 一种调理免疫力低下的膳食 | |
CN104146262A (zh) | 一种调理气郁体质的膳食 | |
CN104000206A (zh) | 一种祛痘的膳食 | |
CN104082737A (zh) | 一种防治肝炎的方便食品 | |
CN104082731A (zh) | 一种食管癌患者食用的微生态特殊膳食 | |
CN104082718A (zh) | 一种大肠肿瘤患者食用的微生态特殊膳食 | |
CN104126791A (zh) | 一种动脉粥样硬化患者食用的微生态特殊膳食 | |
CN104222732A (zh) | 一种肠道炎症性疾病防治的肠道微生态制剂 | |
CN104095181A (zh) | 一种前列腺癌患者食用的微生态特殊膳食 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20141008 |